Loading…
Zenotech Laboratories (BSE 532039)₹39.00+1.46%Pharmaceuticals
Zenotech Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of 4.6% against a peer median of 12.1%, and latest-quarter sales growth of 10.2% against a peer median of 18.7%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambalal Sarabhai Enterprises | 276 | 20.6 | 12.1 | 12.3 | 0.36 | 0.0 | 202 | 18 | 7.9 | −51.5 | vs BSE 532039 |
| Astal Laboratories | 263 | 17.3 | 9.0 | 8.0 | 0.15 | 0.0 | 249 | 15 | — | — | vs BSE 532039 |
| Everest Organics | 255 | 44.6 | 12.0 | 7.6 | 0.66 | 0.0 | 196 | 6 | 19.2 | −9.7 | vs BSE 532039 |
| Sat Kartar Life | 245 | 14.2 | 36.0 | 26.5 | 0.04 | 0.5 | 201 | 17 | 26.7 | 28.4 | vs BSE 532039 |
| BDH Industries | 240 | 22.1 | 19.9 | 14.8 | 0.03 | 1.2 | 96 | 11 | 62.8 | 15.6 | vs BSE 532039 |
| Zenotech Laboratories | 238 | — | 4.6 | −1.2 | 0.00 | 0.0 | 44 | −1 | 10.2 | −145.0 | — |
| Accretion Nutraveda | 237 | 47.2 | 27.8 | 25.1 | 0.12 | 0.0 | 34 | 5 | 80.4 | 56.1 | vs BSE 532039 |
| Accretion Pharmaceuticals | 225 | 23.3 | 28.9 | 27.6 | 0.23 | 0.0 | 89 | 10 | 18.2 | 13.9 | vs BSE 532039 |
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs BSE 532039 |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | vs BSE 532039 |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs BSE 532039 |
| Peer median | 238 | 22.1 | 12.1 | 12.3 | 0.23 | 0.0 | 131 | 10 | 18.7 | 3.6 |
Listed companies closest to Zenotech Laboratories in Pharmaceuticals include Ambalal Sarabhai Enterprises, Astal Laboratories, Everest Organics, Sat Kartar Life, BDH Industries, Accretion Nutraveda, Accretion Pharmaceuticals, Gennex Laboratories.
Ambalal Sarabhai Enterprises, with a market cap of ₹276 Cr.
Zenotech Laboratories' return on capital employed is 4.6%, below the peer median of 12.1%.